Cheesecake Factory stock price target raised to $50 from $45 at UBS

UBS raised its price target for Cheesecake Factory (CAKE) to $50 from $45 but maintained a Sell rating, signaling valuation concerns despite the company's robust operational performance. CAKE has delivered six consecutive quarters of over 20% earnings growth, beat Q1 EPS estimates, and is projected to exceed Q2 same-store sales and EPS consensus, alongside plans for 25 new restaurants in 2025. However, UBS notes the stock's current trading price of $62.38 exceeds its 5-year average EBITDA multiple and their new target. This cautious stance reflects ongoing macroeconomic headwinds and industry pressures, tempering the positive operational momentum.

Analysis

UBS has raised its price target on Cheesecake Factory (CAKE) to $50.00 from $45.00 but paradoxically maintained a Sell rating, signaling a significant disconnect between the company's robust operational performance and its current market valuation. The company demonstrates strong fundamental health, having delivered six consecutive quarters of over 20% earnings growth and a Q1 2025 EPS of $0.93 that surpassed analyst expectations. Furthermore, UBS anticipates continued momentum, projecting Q2 same-store sales growth of 1.5%, ahead of the 1.1% consensus, and EPS to exceed the $1.06 consensus. This operational strength is supported by a healthy 39.65% gross profit margin and a forward-looking plan to open 25 new restaurants in 2025. However, the caution from UBS stems entirely from valuation and macroeconomic risk factors. The stock's current price near $62.38 is not only well above the new $50 target but also reflects an 11x EBITDA multiple, which is a premium to its five-year average of 9x. While management has shown an ability to navigate low single-digit inflation and drive margin improvement, the elevated share price, up 30.5% year-to-date, appears to have priced in much of the positive execution, leaving it vulnerable to shifts in consumer spending or broader industry pressures.

Key Decisions for Investors

• Investors should weigh the company's strong operational execution and consistent earnings beats against its elevated valuation, as the stock is trading at an 11x EBITDA multiple, significantly above its historical average of 9x.
• Monitor the upcoming July 29th earnings report for specific commentary on third-quarter traffic, pricing strategies, and the performance of its North Italia and Flower Child growth brands, as these are critical validation points for the current share price.
• Given the stock price is trading substantially above UBS's new $50 price target, current holders could consider the valuation risk, while prospective investors should exercise caution regarding the entry point despite the positive operational momentum.
• Be mindful of macroeconomic headwinds, as any deterioration in consumer discretionary spending could challenge the company's ability to sustain sales growth and justify its premium valuation.